Revive Therapeutics Ltd. announced the closing of its triangular amalgamation between Mercury Capital III Limited, a wholly owned subsidiary of Mercury Capital, and Revive Therapeutics Inc. In connection with the Amalgamation, all of the directors of Revive Ltd. (other than Carlo Sansalone) have resigned and Thomas Sears has resigned as the Chief Executive Officer and Chief Financial Officer of Revive Ltd. Messrs. Fabio Chianelli, Craig Leon and William Jackson have joined Mr. Sansalone on the board of directors, filling the vacancies created by such resignations. Following completion of the Amalgamation, the management of Revive Ltd. consists of the following individuals: Fabio Chianelli, Director and Chief Executive Officer; Carmelo Marrelli, Chief Financial Officer; Dr. Bev Incledon Vice-President of Research and Development; William Jackson, Director; Carlo Sansalone, Director; Robbie Grossman, Corporate Secretary.

Mr. Chianelli is the founder and President of Revive Inc., and has been the President of Fabiotech Inc. Mr. Marrelli has been a principal of Marrelli Support Services Inc., since February 2009 and, prior to February 2009, a partner with Marrelli & Drake Corporate Services. Mr. Marrelli also serves as the Chief Financial Officer of several mining companies and as a director of Odyssey Resources Limited. Dr. Incledon is currently President of Concept 2 Clinic Inc. Mr. Leon served as the Chief Executive Officer and Chairman of the Board of Titan Medical Inc. from July 2008 to March 2013.

Mr. Jackson is currently Chief Executive Officer of Atwill Medical Solutions. Mr. Jackson was a cofounder of Covalon Technologies Ltd. Mr. Sansalone has been the President of Sanscon Construction Ltd. since 1999. Mr. Grossman was the founder and President of a publishing company.

He is currently an officer and director of several publicly listed issuers.